MDL UMC utrecht Health Strategy on HCV in The Netherlands van Hattum VHPB meeting May 2002.

Slides:



Advertisements
Similar presentations
Hepatitis C in Retrospect David Gladders Portsmouth City Council.
Advertisements

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
Integration of Viral Hepatitis Prevention with STD Prevention: What Health Professionals Should Know Presenter: Jay Todd, Training and Public Education.
GENERAL AWARENESS ON HIV/AIDS Presented by: WeHELP In Association with its MEDICAL TEAM.
Title: PEOPLE LIVING WITH HIV/AIDSIN EGYPT: ROLE OF COMMUNITY PHARMACIST Authors: Nahla Maher Hegab Pharmacy graduate. Institution: College of pharmacy,
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
A Call for Action HIV/AIDS & Hepatitis C in Irish Prisons Irish Penal Reform Trust & Merchants Quay Ireland by Rick Lines, MA July 26, 2002.
Hepatitis C In Alaska’s Department of Corrections
Senate Health Care Committee Briefing: Hepatitis C Treatment Dan Lessler, MD Chief Medical Officer November 20, 2014.
Hepatitis C Rapid Antibody Testing Among At-Risk Populations, Arizona, 2014 Felicia McLean Public Health Associate Office for State, Tribal, Local and.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
‏Hepatitis B Eliminating Transmission Preventing Disease* John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention * The.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Hepatitis B and C: A silent but deadly epidemic Arun J Sanyal M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Richmond, Virginia.
Hepatitis A, B, C Direct Inoculation
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
1 TB/HIV Project in the Philippines Yumiko Yanase.
HIV/AIDS In Botswana. Learning objective…. Explain the impact of HIV and Aids in one African country (Botswana)
Treatment of drug addiction in prisons
Water Services Trust Fund HIV/ AIDS, STD’s and substance abuse 8/29/20151.
Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.
Glencoe Making Life Choices Section 2 HIV and AIDS Chapter 16 Sexually Transmitted Diseases 1 > HOME Content Vocabulary Pneumocystis carinii.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Violation of Rights of People Living with HIV/AIDS in Health Care Setting in Odessa, Ukraine Odessa, Ukraine August 2008 Kostiantyn Zverkov, Director of.
Hepatitis C- Global and National Perspective Dr Allister Grant Consultant Hepatologist University Hospitals Leicester NHS Trust.
National AIDS Program in Palestine Dr. Asad Ramlawi Director General of PHC.
Wyoming Department of Health Communicable Diseases
Hepatitis B Virus 28.
Prevention and improved treatment of communicable diseases (HIV/AIDS and TB), including increasing preparedness for bioterrorism and epidemics Anneli Taal,
Application of Patients’ Rights in Cross-Border Health Care Regional meeting and workshop February 2009 Budapest ŠKUC – Magnus, SLOVENIA Miran Šolinc.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Prabhdeep Sidhu Candidate PharmD 2015 Western University of Health Sciences Mar 28, 2014.
A TRANSMITTABLE DISEASE AIDS. WHY AIDS? Geographers are concerned with the Geography of AIDS because it has not spread evenly throughout the world and.
The Viral Hepatitis Prevention Board, 10 years of support to the control and prevention of viral hepatitis in Europe. Alex Vorsters Viral Hepatitis Prevention.
Sara Stevenson Hepatitis B Nurse Specialist St James’s Hospital, Leeds.
21/2/ Viral Hepatitis B (HBV) Associate Professor Family and Community Medicine Department King Saud University.
HIV AIDS Africa’s Pandemic?
The Swiss Population In 2001 Resident population: 7,258,500 Population density: 176 per Km 2 Foreign nationals: 20.1% (~1,460,000) Excess of births over.
Hepatitis C in Pakistan. Abstract  The Government of Pakistan is striving to provide comprehensive health coverage to its people and the efforts to strengthening.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
Hepatitis C.
Bloodborne Pathogens BPW Medical Associates. Bloodborne Pathogens Hep B, Hep C, HIV, Malaria Can be transmitted via blood, CSF, synovial fluid, pleural.
Hepatitis C Dr R V S N Sarma., M.D Consultant Physician.
Evidence-based practice guidelines: Chronic harms of substance use.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
From discovery to cure in 25 years -- the Hepatitis C story Mel Krajden MD, FRCPC Medical Head, Hepatitis Acting Medical Director, Public Health Laboratory.
Chapter Seventeen The HIV/AIDS Crisis and Sexual Decisions.
2015 Mercury : 1392BE15NP Objective measure the awareness and knowledge about the Hepatitis C virus among the Belgian population transmission.
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Rauni Ruohonen FILHA Priorities of TB control in penitentiary care.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
National Health Insurance Bahamas February, 2016.
Role of Ministry of Health and Medical Education in management and control of Hepatitis C 2016/07/13.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Hepatitis C Virus Program in Chicago
NDPHS PHC EG Draft Workshop report, Attachment 3
This is an archived document.
Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,
Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
HCV Screening.
Viral Hepatitis Prevention Board Secretariat
UNAIDS/WHO POLICY ON HIV TESTING June 2004
Blood borne viral hepatitis action in Wales
Presentation transcript:

MDL UMC utrecht Health Strategy on HCV in The Netherlands van Hattum VHPB meeting May 2002

MDL UMC utrecht Health Strategy on HCV in The Netherlands epidemiology observations recommendations VHPB meeting May 2002

MDL UMC utrecht HCV in The Netherlands Epidemiology

MDL UMC utrecht HCV in The Netherlands Epidemiology prevalence in the general population new blood donors:0.04 % estimated in general population: 5-10x blood donors :<0.2 % general population (low risk profile) : 0.1 % general population (extrapolated) :<0.4 % HCV observed in “random” population: %

MDL UMC utrecht HCV in The Netherlands Epidemiology prevalence in recipients of blood products haemophiliacs (81 %) 1150 haemodialysis (2.7 %) 110 blood transfusions (est.) ~ 0.1 % of general population

MDL UMC utrecht HCV in The Netherlands Epidemiology prevalence, other groups ivd users (75 %) allochtonous ( %) <25000 ~ 0.2 % of general population hospital infection, needle stick, transplantation, dentist household, perinatal, sexual, tattoo/piercing

MDL UMC utrecht HCV in The Netherlands Epidemiology prevalence General population HCV observed in “random” population: % Risk groups recipients of blood products0.1 % ivd users0.08 % allochtonous0.15 % risky behaviour <0.1 % % ~ people, where are they ?

MDL UMC utrecht HCV in The Netherlands Basic Facts Minister of Health, Welfare and Sports Health Council of the Netherlands chronic hepatitis C is a serious disease hepatitis C virus can be detected with great accuracy hep C is aggravated by hep A, hep B, HIV or alcohol treatment is available and may result in elimination of the HCV and cure

MDL UMC utrecht HCV in The Netherlands Basic Facts Minister of Health, Welfare and Sports Health Council of the Netherlands overall prevalence is considered to be comparable to other countries in Northern Europe most prevalent risk groups: people who have used intravenous drugs recipients of blood products allochtonous descent general or focused screening programs to detect sporadic HC patients seem inefficient

MDL UMC utrecht HCV in The Netherlands Basic Facts Minister of Health, Welfare and Sports Health Council of the Netherlands HCV is transmitted mainly via blood or blood products hygienic measures among non-regular practitioners (tattoo, piercing, acupuncture, ritual) are unclear

MDL UMC utrecht HCV in The Netherlands Basic Facts Minister of Health, Welfare and Sport Health Council of the Netherlands it is the patients’ right that physicians provide them spontaneously with relevant information the general population lacks adequate knowledge about HCV, the transmission routes, the disease and possible treatment this prevents them from taking responsibility for their own health

MDL UMC utrecht HCV in The Netherlands Recommendations Minister of Health, Welfare and Sport Health Council of the Netherlands a general look back, i.e. tracing and testing all people possibly at risk in the past would be inefficient hospitals should keep precise records of the origin and use of blood products epidemiological research is required as to the prevalence of HCV infection in the various population groups children of HCV positive mothers first generation of allochtonous descent

MDL UMC utrecht HCV in The Netherlands Recommendations Minister of Health, Welfare and Sport Health Council of the Netherlands tracing and treating patients with conditions that go along with increased likelihood of HCV infection haemophiliacs haemodialysis patients polytransfusees patients with organ transplants patients with puncture wounds patients with hep C must be advised to stop alcohol

MDL UMC utrecht HCV in The Netherlands Recommendations Minister of Health, Welfare and Sport Health Council of the Netherlands medical doctors of various disciplines must be trained on diagnostics and advising patients professionals involved in increased risk of HCV transmission must be informed on hygiene hair dressers chiropodists acupuncturists piercing / tattoo practitioners ritual practitioners

MDL UMC utrecht HCV in The Netherlands Recommendations Minister of Health, Welfare and Sport Health Council of the Netherlands information to the general population the disease the transmission the possibility to treat goal-oriented information to people in risk groups seek medical care if necessary, receive treatment Immigrants should be informed through their own channels intermediaries should be trained for that purpose

MDL UMC utrecht HCV in The Netherlands active awareness programs in risk groups training courses to professionals in cooperation with the various professional societies special aspects concerning each professional group aiming at hygienic measures providing information to clients / patients diagnosing new patients providing treatment current situation Hepatitis C Surveillance study 1999/2000 mixed population, 1.5 million, 1.5 year 78 new hepatitis C patients diagnosed 19 referred to internist / gastroenterologist 3 treated with IFN + ribavirin Hepatitis C Surveillance study 1999/2000 mixed population, 1.5 million, 1.5 year 78 new hepatitis C patients diagnosed 19 referred to internist / gastroenterologist 3 treated with IFN + ribavirin

MDL UMC utrecht HCV in The Netherlands active awareness programs in risk groups training courses to professionals in cooperation with the various professional societies special aspects concerning each professional group aiming at hygienic measures providing information to clients / patients diagnosing new patients providing treatment special treatment programs of risk groups current situation HC treatment of (ex) i.v. drug users starting up nation wide pilot study: - feasible if using infrastructure of drug user control programs if the present staff is trained - good compliance IFN 6 months, 56 patients, 2 dropouts In NLmost drug addicts are registered in programs everybody has a (mandatory) health insurance HC treatment (IFN+riba) is available and refundable HC treatment of (ex) i.v. drug users starting up nation wide pilot study: - feasible if using infrastructure of drug user control programs if the present staff is trained - good compliance IFN 6 months, 56 patients, 2 dropouts In NLmost drug addicts are registered in programs everybody has a (mandatory) health insurance HC treatment (IFN+riba) is available and refundable

MDL UMC utrecht Health Strategy on HCV in The Netherlands collect data on epidemiology and support research improve the awareness of the disease and hygiene general population risk groups improve recognition of the disease and hygiene by non-medical practitioners by medical professionals improve treatment of the disease stimulate referral: non-medical, general practitioner, specialist stimulate adequate treatment by the specialists support treatment programmes for risk groups summary

MDL UMC utrecht Health Strategy on HCV in The Netherlands van Hattum end VHPB meeting May 2002